Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

XSEC:002675 Lagerbericht

Marktkapitalisierung: CN¥10.9b

Yantai Dongcheng Pharmaceutical GroupLtd Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Yantai Dongcheng Pharmaceutical GroupLtd is forecast to grow earnings and revenue by 45.9% and 13.1% per annum respectively. EPS is expected to grow by 45.8% per annum. Return on equity is forecast to be 7.6% in 3 years.

Wichtige Informationen

45.9%

Wachstumsrate der Gewinne

45.8%

EPS-Wachstumsrate

Biotechs Gewinnwachstum44.8%
Wachstumsrate der Einnahmen13.1%
Zukünftige Eigenkapitalrendite7.6%
Analystenabdeckung

Good

Zuletzt aktualisiert01 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Gewinn- und Umsatzwachstumsprognosen

XSEC:002675 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20263,906424N/A7605
12/31/20253,452327N/A6646
12/31/20243,119258N/A6486
9/30/20242,85391-167362N/A
6/30/20242,911137-280247N/A
3/31/20243,072224-340204N/A
12/31/20233,276210-235277N/A
9/30/20233,42726335490N/A
6/30/20233,603323199664N/A
3/31/20233,554302467853N/A
1/1/20233,583307607997N/A
9/30/20223,858220415986N/A
6/30/20223,851165292833N/A
3/31/20223,902140295846N/A
1/1/20223,912152413944N/A
9/30/20213,637341445788N/A
6/30/20213,5993537021,023N/A
3/31/20213,596411333618N/A
12/31/20203,419418310573N/A
9/30/20203,395214339645N/A
6/30/20203,312196149443N/A
3/31/20203,172164508760N/A
12/31/20192,993155446696N/A
9/30/20192,877366335500N/A
6/30/20192,709347458577N/A
3/31/20192,467302305457N/A
12/31/20182,333280372493N/A
9/30/20182,098228458600N/A
6/30/20181,842212N/A444N/A
3/31/20181,679185N/A339N/A
12/31/20171,596173N/A209N/A
9/30/20171,511172N/A79N/A
6/30/20171,377149N/A106N/A
3/31/20171,245145N/A106N/A
12/31/20161,158131N/A196N/A
9/30/20161,014119N/A210N/A
6/30/201690395N/A109N/A
3/31/201685283N/A103N/A
12/31/201579590N/A67N/A
9/30/201572594N/A36N/A
6/30/201572499N/A40N/A
3/31/2015727103N/A-16N/A
12/31/2014751104N/A52N/A
9/30/201478699N/A2N/A
6/30/201478396N/A-10N/A
3/31/201478291N/A66N/A
12/31/2013775101N/A-21N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 002675's forecast earnings growth (45.9% per year) is above the savings rate (2.9%).

Ertrag vs. Markt: 002675's earnings (45.9% per year) are forecast to grow faster than the CN market (25.8% per year).

Hohe Wachstumserträge: 002675's earnings are expected to grow significantly over the next 3 years.

Einnahmen vs. Markt: 002675's revenue (13.1% per year) is forecast to grow slower than the CN market (14% per year).

Hohe Wachstumseinnahmen: 002675's revenue (13.1% per year) is forecast to grow slower than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 002675's Return on Equity is forecast to be low in 3 years time (7.6%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y